5 terminated. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Terminated 5 |
| Phase 2 | 1 | Terminated 1 |
Follow Ischemic Attack, Transient: new trials by email Literature Review of Ischemic Attack, Transient trials Research Report on Ischemic Attack, Transient
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) Rivaroxaban (Xarelto, BAY59-7939), Acetylsalicylic acid (Aspirin, BAY1019036), Rivaroxaban-Placebo - Stroke | Phase 3 | Terminated | Bayer | 7213 | 2014-12-23 | 2019-01-09 |
| Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial Clopidogrel, placebo - Ischemic Attack, Transient | Phase 3 | Terminated | University of California, San Francisco | 4881 | 2010-05-28 | 2018-12-04 |
| VISSIT Intracranial Stent Study for Ischemic Therapy Pharos Vitesse Neurovascular Stent System (Stent implantation) + Medical therapy (Aspirin and Clopidogrel), Aspirin and Clopidogrel (Medical therapy) - Ischemic Stroke, Transient Ischemic Attack | Phase 2 / Phase 3 | Terminated | Codman & Shurtleff | 125 | 2008-10-01 | 2015-02-20 |
| Carotid Occlusion Surgery Study extracranial-intracranial bypass surgery, best medical therapy - Stroke, Ischemic Attack, Transient | Phase 3 | Terminated | University of North Carolina, Chapel Hill | 700 | 2002-07-01 | 2012-03-27 |
| Aspirin Or Warfarin To Prevent Stroke Warfarin, Aspirin - Stroke, Cerebral Infarction | Phase 3 | Terminated | National Institute of Neurological Disorders and Stroke (NINDS) | 2006-06-06 |
Stroke (3) · Cerebral Infarction (2) · Ischemic Stroke (2) · Atherosclerosis (1) · Cerebrovascular Disorders (1) · Constriction, Pathologic (1) · Thromboembolism (1)
Brain Diseases (5) · Brain Ischemia (5) · Cardiovascular Diseases (5) · Central Nervous System Diseases (5) · Nervous System Diseases (5) · Vascular Diseases (5) · Cerebrovascular Disorders (4) · Brain Infarction (2) · Infarction (2) · Ischemia (2) · Necrosis (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1)
Aspirin (3) · Clopidogrel (2) · Cerebral Revascularization (1) · Rivaroxaban (1) · Warfarin (1)
Bayer (1) · Codman & Shurtleff (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · University of California, San Francisco (1) · University of North Carolina, Chapel Hill (1)
United States (4) · Australia (2) · Canada (2) · Finland (2) · France (2) · Germany (2) · Mexico (2) · Spain (2) · United Kingdom (2) · Argentina (1) · Austria (1) · Belgium (1) · Brazil (1) · Chile (1) · China (1)
Anthony S. Kim, MD, MAS (1) · J. Donald Easton, MD (1) · Marc Chimowitz (1) · S. Claiborne Johnston, MD, PhD (1) · William J. Powers, M.D. (1)
PMID 22068990, PMID 23101451, PMID 23879752, PMID 25803346, PMID 26464429, PMID 29525076, PMID 29766750, PMID 29766772, PMID 31008276, PMID 31034032, PMID 31238700, PMID 31401971, PMID 31490536, PMID 31526123, PMID 32056346, PMID 32078486, PMID 32091536, PMID 32295509, PMID 32517582, PMID 32568642, PMID 32628266, PMID 32640945, PMID 33074284, PMID 34538089, PMID 34694346, PMID 34791941, PMID 35043692, PMID 35538232, PMID 38174567, PMID 39222701, PMID 39358761, PMID 41717934